Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity.
作者信息
Mingozzi Federico, Büning Hildegard
机构信息
Généthon , Evry , France ; INSERM U974, Université Pierre et Marie Curie (Paris 6) , Paris , France.
Center for Molecular Medicine Cologne (CMMC), University of Cologne , Cologne , Germany ; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne , Bonn , Germany ; Department I of Internal Medicine, University Hospital of Cologne , Cologne , Germany.
出版信息
Front Immunol. 2015 Mar 17;6:120. doi: 10.3389/fimmu.2015.00120. eCollection 2015.
Abstract
摘要
相似文献
1
Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity.
Front Immunol. 2015 Mar 17;6:120. doi: 10.3389/fimmu.2015.00120. eCollection 2015.
2
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Pharmacol Ther. 2020 Mar;207:107453. doi: 10.1016/j.pharmthera.2019.107453. Epub 2019 Dec 11.
3
Immune responses to retinal gene therapy using adeno-associated viral vectors - Implications for treatment success and safety.
Prog Retin Eye Res. 2021 Jul;83:100915. doi: 10.1016/j.preteyeres.2020.100915. Epub 2020 Oct 15.
4
Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep.
PLoS One. 2017 Jan 31;12(1):e0171132. doi: 10.1371/journal.pone.0171132. eCollection 2017.
5
Innate Immune Sensing of Adeno-Associated Virus Vectors.
Hum Gene Ther. 2024 Jul;35(13-14):451-463. doi: 10.1089/hum.2024.040. Epub 2024 Jul 5.
6
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia.
J Clin Med. 2021 Jun 2;10(11):2471. doi: 10.3390/jcm10112471.
7
Immune responses to adeno-associated virus vectors.
Curr Gene Ther. 2005 Jun;5(3):323-31. doi: 10.2174/1566523054065039.
8
Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
Expert Opin Biol Ther. 2021 Jun;21(6):749-766. doi: 10.1080/14712598.2021.1865303. Epub 2020 Dec 30.
9
Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01011-18. Print 2018 Oct 15.
10
Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Front Immunol. 2014 Feb 7;5:28. doi: 10.3389/fimmu.2014.00028. eCollection 2014.
引用本文的文献
1
AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear.
Mol Ther Methods Clin Dev. 2025 Mar 21;33(2):101456. doi: 10.1016/j.omtm.2025.101456. eCollection 2025 Jun 12.
2
Effects of Thermally Induced Configuration Changes on rAAV Genome's Enzymatic Accessibility.
Mol Ther Methods Clin Dev. 2020 Jun 10;18:328-334. doi: 10.1016/j.omtm.2020.06.005. eCollection 2020 Sep 11.
3
Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease.
Circ Res. 2020 Feb 28;126(5):663-678. doi: 10.1161/CIRCRESAHA.119.315856. Epub 2020 Feb 27.
4
Molecular Mechanisms and Determinants of Innovative Correction Approaches in Coagulation Factor Deficiencies.
Int J Mol Sci. 2019 Jun 21;20(12):3036. doi: 10.3390/ijms20123036.
5
Emerging Issues in AAV-Mediated Gene Therapy.
Mol Ther Methods Clin Dev. 2017 Dec 1;8:87-104. doi: 10.1016/j.omtm.2017.11.007. eCollection 2018 Mar 16.
6
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies.
Mol Ther Methods Clin Dev. 2016 Nov 16;3:16068. doi: 10.1038/mtm.2016.68. eCollection 2016.
7
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.
Hum Gene Ther. 2016 Jul;27(7):478-96. doi: 10.1089/hum.2016.087.
8
Establishment of two quantitative nested qPCR assays targeting the human EPO transgene.
Gene Ther. 2016 Apr;23(4):330-9. doi: 10.1038/gt.2016.2. Epub 2016 Jan 11.
9
The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses.
PLoS Pathog. 2015 Dec 1;11(12):e1005281. doi: 10.1371/journal.ppat.1005281. eCollection 2015 Dec.
本文引用的文献
1
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
N Engl J Med. 2014 Nov 20;371(21):1994-2004. doi: 10.1056/NEJMoa1407309.
2
Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.
Front Immunol. 2014 Jul 23;5:350. doi: 10.3389/fimmu.2014.00350. eCollection 2014.
3
Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside.
Front Immunol. 2014 Mar 3;5:82. doi: 10.3389/fimmu.2014.00082. eCollection 2014.
4
Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Front Immunol. 2014 Feb 7;5:28. doi: 10.3389/fimmu.2014.00028. eCollection 2014.
5
Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells.
Front Immunol. 2014 Feb 3;5:35. doi: 10.3389/fimmu.2014.00035. eCollection 2014.
6
Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors.
Front Immunol. 2014 Jan 30;5:9. doi: 10.3389/fimmu.2014.00009. eCollection 2014.
7
AAV Vectors Vaccines Against Infectious Diseases.
Front Immunol. 2014 Jan 21;5:5. doi: 10.3389/fimmu.2014.00005. eCollection 2014.
8
Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice.
Front Immunol. 2014 Jan 6;4:502. doi: 10.3389/fimmu.2013.00502.
9
Humoral Immune Response to AAV.
Front Immunol. 2013 Oct 18;4:341. doi: 10.3389/fimmu.2013.00341.
10
Immunological Monitoring to Rationally Guide AAV Gene Therapy.
Front Immunol. 2013 Sep 12;4:273. doi: 10.3389/fimmu.2013.00273.
Zotero 插件